MELTZ MARK A (COO General Counsel Treasurer) reported 1 transaction at KINNATE BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/6/2023ACC: 0001209191-23-048426
Officer· COO General Counsel Treasurer
Since Dec 2020
-541.00
Net shares
Net seller
$1.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
541.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−541.00
Price / share
$2.35
Trade value
$1.27K
% of position
1.9%
9/1/2023
29.22K→28.68K
Total
Net shares
−541.00
Net value
-$1.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2023 | F · Tax Withholding | −541.00 | $2.35 | $1.27K | 1.9% | 29.22K | 28.68K |
| Total | −541.00 | -$1.27K | ||||||
Derivative Transactions0
No derivative transactions reported